Introgression decreases allelic shuffling. by Enrique J. Schwarzkopf (6579275)

All data points from Fig 2. by Sara Hijazi (21656615)

All data points from Fig 5. by Sara Hijazi (21656615)

All data points from Fig 8. by Sara Hijazi (21656615)

All data points from Fig 3. by Sara Hijazi (21656615)

All data points from Fig 1. by Sara Hijazi (21656615)

All data points from Fig 4. by Sara Hijazi (21656615)

All data points from Fig 9. by Sara Hijazi (21656615)

All data points from Fig 7. by Sara Hijazi (21656615)

All data points from Fig 6. by Sara Hijazi (21656615)

Kaplan-Meier analysis showing cumulative incidence of all-cause mortality by number of cognitive activities. by Linjia Duan (13276989)

Subjects:

Stratified analyses by potential modifiers of the association between the number of cognitive activities and all-cause mortality. by Linjia Duan (13276989)

Subjects:

All data points from S1 to S5 Figs as well as the supplementary method table. by Sara Hijazi (21656615)

Innovation and night light in large and small cities. by Saul Estrin (8629173)

Associations of number of cognitive activities with all-cause mortality and medication analysis of number of cognitive activities by baseline cognitive function. by Linjia Duan (13276989)

Subjects:

Comparison of renal tissue pathological damage grades across different groups at all time points. by Jian-feng Li (8667645)

Subjects:

Summary map of all contacts with statistically significant SVM classifications. by Alexander P. Rockhill (6053618)

“…Yellow reflects high classification accuracy, while dark blue represents less robust classification accuracy. Time-frequency points with no significant classification value are white.…”

Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. by Søren Egstrand (10906087)

“…All groups were compared by Kruskal Wallis test with <i>post hoc</i> test after Dunn with Bonferroni adjustment showing significant decreased Ki-67 labeling index of <i>Cina1</i> compared to <i>Cina2</i> (p = 0.006) and the untreated CKD groups (p = 0.0001 and p = 0.0002, respectively). …”

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Patient demographic information at four time points. by Ruitian Song (11045127)

Subjects: